Clinical features of respiratory syncytial virus bronchiolitis in an infant: rapid and fatal brain involvement

Paolo Bottino1, Rebecca Miglino2, Lisa Pastrone2

  • 1A.O.U. "Citta della Salute e della Scienza di Torino", S.C. Microbiology and Virology U., Corso Bramante n. 88, 10126, Turin, TO, Italy. paolo.bottino@unito.it.

BMC Pediatrics
|December 10, 2021
PubMed

Insights

Respiratory Syncytial Virus (RSV) can cause severe neurological damage and sudden infant death, even without obvious brain injury signs. This case highlights the critical need to consider RSV

Area of Science:

  • Pediatrics
  • Virology
  • Neurology

Background:

  • Respiratory Syncytial Virus (RSV) is a primary cause of infant hospitalization and mortality globally, mainly through bronchiolitis and pneumonia.
  • Emerging evidence highlights extrapulmonary manifestations of RSV, particularly neurological complications, necessitating evaluation even without overt signs of brain involvement.

Observation:

  • A 40-day-old infant presented with severe RSV bronchiolitis, hypoxemia, and respiratory acidosis, initially improving with oxygen therapy.
  • Clinical deterioration led to preparation for intubation, but the infant died; no neurological signs were evident during emergency care.
  • Post-mortem examination revealed lung congestion, atelectasis, and significant brain white matter degradation with edema.

Findings:

  • Autoptic analysis confirmed widespread RSV genome presence in respiratory, meningeal, pericardial, abdominal, lung, and brain tissues.
  • The case demonstrates systemic RSV dissemination leading to fatal neurological damage and sudden infant death.

Implications:

  • This case underscores the neurotropic potential of RSV and its role in sudden infant death, often underestimated.
  • Clinicians must maintain a high index of suspicion for neurological involvement in severe RSV cases, irrespective of apparent neurological symptoms.
  • Further research into RSV neurotropism is crucial for developing targeted interventions and improving infant outcomes.
Abstract

Related Concept Videos

Acute Respiratory Failure-IV01:23

Acute Respiratory Failure-IV

Respiratory failure can manifest suddenly or gradually, characterized by a rapid decline in PaO2 and a rapid rise in PaCO2. This situation indicates a severe respiratory problem that may quickly become a life-threatening emergency. One of the early signs of hypoxemic Acute Respiratory Failure (ARF) is a change in mental status due to the brain's sensitivity to oxygen levels and changes in acid-base balance. Symptoms such as restlessness, confusion, and agitation suggest inadequate oxygen...
267
Acute Respiratory Failure-III01:30

Acute Respiratory Failure-III

Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
377
Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
232
Acute Respiratory Failure-I01:21

Acute Respiratory Failure-I

Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
386
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
422
Pulmonary Cycle: Exhalation01:17

Pulmonary Cycle: Exhalation

In terms of human respiration, the act of expelling air, known as exhalation (or expiration), operates on the principle of pressure gradients. During expiration, the pressure within the lungs exceeds that of the surrounding atmosphere. Under normal conditions, quiet breathing involves passive exhalation and is free of muscular contractions. This is because the exhalation process is driven by the natural elastic recoil of the lungs and chest wall, both of which have an inherent tendency to...
2.0K